Procter & Gamble (PG): CEO sold ~$478K
Paul Gama, CEO at Procter & Gamble, sold ~$478K of Procter & Gamble shares.
- ~$478K
- Approx. value · 2,894 sh @ $165.00
- 44K
- Holds after · shares reported
- Traded
- Oct 30, 2026
- Filed
- Nov 3, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Aug 5, 2026CongressDisclosed sale of PG — reported range $1,001 - $15,000
- Aug 17, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
- Aug 24, 2026CongressDisclosed sale of PG — reported range $50,001 - $100,000
- Sep 8, 2026CongressDisclosed purchase of PG — reported range $1,001 - $15,000
- Oct 5, 2026Insider · 3 peopleInsiders: 3 sales (~$1.2M)
- Oct 8, 2026CongressDisclosed sale of PG — reported range $1,001 - $15,000
- Oct 12, 2026CongressDisclosed sale of PG — reported range $1,001 - $15,000
- Oct 22, 2026Company filing · Form 8-K · ResultsReported its results
- Oct 23, 2026Insider · 3 peopleInsiders: 3 sales (~$7.1M)
- Oct 23, 2026Congress · 1 personMembers of Congress: 2 purchases
- Oct 30, 2026 · this disclosureInsiderCEO sold ~$478K of PG shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Procter & Gamble
For Procter & Gamble, OQRO holds 37 insider filings (SEC Form 4 or Form 144), 10 Congress trade reports and 71 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PG page.
Other recent filings by Paul Gama, CEO- Health Care
- SEC Form 4 at Procter & Gamble (PG)Oct 26, 2026
- SEC Form 4 at Procter & Gamble (PG)Oct 6, 2026
- SEC Form 4 at Procter & Gamble (PG)Aug 24, 2026
The full history of Paul Gama, CEO- Health Care is on the profile page.
How this filing works
Explore the data
Other disclosures at Procter & Gamble
- House Clerk periodic transaction reportNov 5, 2026
- House Clerk periodic transaction reportNov 5, 2026
- SEC Form 4Nov 5, 2026
- SEC Form 4Nov 3, 2026
- SEC Form 4Nov 3, 2026
- SEC Form 4Nov 3, 2026
Everything OQRO holds on this company is on its PG page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
